TDMS Study 05162-10 Pathology Tables
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus DIETHANOLAMINE DATE: 06/11/96
EXPERIMENT: 05162 TEST: 10 TIME: 08:53:44
CAGES FROM 0000 TO LAST CAGE PAGE: 1
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55174D
CONT: N01-ES-05293 CAS: 111-42-2
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: MICE STRAIN: B6C3F1 SEX: MALE START-DATE: 10/22/90 WEEKS ON DOSE: 295
ENDING DATE: 06/11/96
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 2.250000 4.500000 9.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50 0/50
PAPILLOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0 0
WEEK OF ONSET (7) 0 0 0 0
CARCINOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0 0
WEEK OF ONSET (7) 0 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus DIETHANOLAMINE DATE: 06/11/96
EXPERIMENT: 05162 TEST: 10 TIME: 08:53:44
CAGES FROM 0000 TO LAST CAGE PAGE: 2
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55174D
CONT: N01-ES-05293 CAS: 111-42-2
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: MICE STRAIN: B6C3F1 SEX: MALE START-DATE: 10/22/90 WEEKS ON DOSE: 295
ENDING DATE: 06/11/96
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 2.250000 4.500000 9.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50 0/50
PAPILLOMAS AND CARCINOMAS COMBINED
NUMBER / NUMBER SURVIVING (2) 0/0000 0/0000 0/0000 0/0000
PERCENT (3) 0.00 % 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0 0
WEEK OF ONSET (7) 0 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus DIETHANOLAMINE DATE: 06/11/96
EXPERIMENT: 05162 TEST: 10 TIME: 08:53:44
CAGES FROM 0000 TO LAST CAGE PAGE: 3
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55174D
CONT: N01-ES-05293 CAS: 111-42-2
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: MICE STRAIN: B6C3F1 SEX: FEMALE START-DATE: 10/22/90 WEEKS ON DOSE: 295
ENDING DATE: 06/11/96
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 2.250000 4.500000 9.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50 0/50
PAPILLOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0 0
WEEK OF ONSET (7) 0 0 0 0
CARCINOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0 0
WEEK OF ONSET (7) 0 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus DIETHANOLAMINE DATE: 06/11/96
EXPERIMENT: 05162 TEST: 10 TIME: 08:53:44
CAGES FROM 0000 TO LAST CAGE PAGE: 4
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55174D
CONT: N01-ES-05293 CAS: 111-42-2
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: MICE STRAIN: B6C3F1 SEX: FEMALE START-DATE: 10/22/90 WEEKS ON DOSE: 295
ENDING DATE: 06/11/96
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 2.250000 4.500000 9.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50 0/50
PAPILLOMAS AND CARCINOMAS COMBINED
NUMBER / NUMBER SURVIVING (2) 0/0000 0/0000 0/0000 0/0000
PERCENT (3) 0.00 % 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0 0
WEEK OF ONSET (7) 0 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus DIETHANOLAMINE DATE: 06/11/96
EXPERIMENT: 05162 TEST: 10 TIME: 08:53:44
CAGES FROM 0000 TO LAST CAGE PAGE: 5
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55174D
CONT: N01-ES-05293 CAS: 111-42-2
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: MICE STRAIN: B6C3F1 SEX: FEMALE START-DATE: 10/22/90 WEEKS ON DOSE: 295
ENDING DATE: 06/11/96
----------------------------------------------------------------------------------------------------------------------------------
************************************************************************
**** END OF REPORT DATA ***
************************************************************************